Delivery Order SPE2DB22D3011-SPE2DB25FQ2LE
Award Date 8/26/25
Potential Completion Date 8/27/25
Potential Value $39K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,994.81 by the Defense Logistics Agency on August 26, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract utilizes firm fixed price pricing with no set-aside designation, indicating the award was competitively procured. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed price delivery order valued at $6,636.12 by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens with a completion date of June 2, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency Medical Supply Chain valued at $4,383.54 for the supply of Zepbound 5 mg/0.5 ml pen injections. This firm fixed price, non-set-aside contract was awarded on July 30, 2025, with a completion date of July 31, 2025. The delivery order represents a continuation of the company's substantial pharmaceutical supply relationship with the Defense Logistics Agency,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,459.86 by the Defense Logistics Agency on September 15, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL). The contract is classified as a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at the company's location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation applied. This delivery order is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injectors in 0.5 mL quantities, with a contract ceiling value of $8,359.40 and an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and veteran healthcare...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $3,431.61 on August 21, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen's larger relationship...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $9,040.82 by the Defense Logistics Agency (DLA) for Zepbound 5 mg/0.5 ml pens. The award was made on September 10, 2025, with an ultimate completion date of September 11, 2025, under firm fixed pricing with no set-aside designation. This delivery order represents a competitive award issued against AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,906.47 by the Defense Logistics Agency for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. The ultimate completion date is August 15, 2025, with performance to be conducted at the contractor's Conshohocken facility. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $3,812.90 by the Defense Logistics Agency's Medical Supply Chain on August 15, 2025, with completion scheduled for August 18, 2025. The contract covers the supply of Zepbound 5 mg/0.5 mL pen injections and represents a non-competitive, competitively awarded delivery order under the company's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $9,927.33 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier to the federal government. The order will be fulfilled from the contractor's location in Conshohocken,...